beta-leucine : A beta-amino acid that is pentanoic acid substituted at positions 3 and 4 by amino and methyl groups respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 193411 |
| CHEBI ID | 72772 |
| SCHEMBL ID | 545348 |
| MeSH ID | M0089596 |
| Synonym |
|---|
| 5699-54-7 |
| l-beta-leucine |
| OPREA1_308963 |
| beta-leucine |
| STK504550 |
| dl-beta-leucine, >=98.0% (nt) |
| 3-amino-4-methylpentanoic acid , |
| AKOS000265956 |
| ()-3-amino-4-methylvaleric acid |
| dl-beta-leucine |
| BMSE000466 |
| pentanoic acid, 3-amino-4-methyl- |
| ()-3-amino-4-methylpentanoic acid |
| A8142 |
| 3-amino-4-methyl-pentanoic acid |
| CHEBI:72772 |
| FT-0630332 |
| 7T-0026 |
| S6142 |
| AKOS016340111 |
| dl-homo-beta-valine |
| pentanoic acid,3-amino-4-methyl- |
| SCHEMBL545348 |
| racemic 3-amino-4-methylpentanoic acid |
| J-502209 |
| mfcd01076233 |
| mfcd01076231 |
| a-aminoisobutylessigsaure |
| FT-0698939 |
| FT-0698388 |
| J-511622 |
| mfcd00800505 |
| CS-W013424 |
| HY-W012708 |
| SY016724 |
| Q27140136 |
| SY077258 |
| F0913-5477 |
| AMY30425 |
| beta-aminoisocaproic acid |
| dl-homovaline |
| SY064256 |
| pentanoic acid,3-amino-4-methyl-, (3r)- |
| AB88540 |
| DTXSID50863602 |
| EN300-120454 |
| Z975823290 |
| PD099486 |
| Role | Description |
|---|---|
| human metabolite | Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens). |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Class | Description |
|---|---|
| beta-amino acid | A non-proteinogenic amino acid in which the amino group is located on the carbon atom at the position beta to the carboxy group. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 8 (72.73) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (19.41) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 2 (18.18%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (81.82%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||